Synthetic Biologics, Inc. (NYSEMKT:SYN)

CAPS Rating: 1 out of 5

A development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and fibrotic diseases.

Recs

0
Player Avatar chk999 (99.98) Submitted: 7/6/2012 2:15:19 PM : Underperform Start Price: $1.79 SYN Score: +13.79

Losing money.

Featured Broker Partners


Advertisement